22005583|t|Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Abeta3-10 induces Th2 immune response against amyloid-beta in wild-type mouse.
22005583|a|To develop a safe and efficient vaccine for the treatment of Alzheimer's disease, we constructed a novel adenovirus vaccine encoding ten repeats of Abeta3-10 and CpG motif as an adjuvant and investigated the immune response in BALB/c mouse after intranasal inoculation with this vaccine. The Ad-10xAbeta3-10-CpG induces an IgG1 predominant humoral response and production of IL-4 and IL-10 in splenocytes in vitro, indicating a Th2-polarized immune response. Stimulation of splenocytes with Abeta3-10 peptide induces robust proliferation but not with full-length Abeta42 peptide, demonstrating that Ad-10xAbeta3-10-CpG does not induces Abeta42 specific T cell immune response. The findings raise the possibility that the adenovirus vaccine Ad-10xAbeta3-10-CpG could be a safe and effective alternative for immunotherapy in Alzheimer's disease.
22005583	31	41	adenovirus	Species	10508
22005583	146	151	mouse	Species	10090
22005583	214	233	Alzheimer's disease	Disease	MESH:D000544
22005583	258	268	adenovirus	Species	10508
22005583	380	386	BALB/c	CellLine	CVCL:0184
22005583	387	392	mouse	Species	10090
22005583	445	460	Ad-10xAbeta3-10	CellLine	CVCL:ZW00
22005583	476	480	IgG1	Gene	16017
22005583	528	532	IL-4	Gene	16189
22005583	537	542	IL-10	Gene	16153
22005583	752	767	Ad-10xAbeta3-10	CellLine	CVCL:ZW00
22005583	874	884	adenovirus	Species	10508
22005583	893	908	Ad-10xAbeta3-10	CellLine	CVCL:ZW00
22005583	976	995	Alzheimer's disease	Disease	MESH:D000544

